Cargando…
Metabolic vulnerabilities of metastasizing cancer cells
Most cancer patients die due to metastasis formation. Therefore, understanding, preventing, and treating metastatic cancers is an unmet need. Recent research indicates that cancer cells that undergo metastasis formation have a distinct metabolism that can be targeted. Here, I would like to discuss p...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6621976/ https://www.ncbi.nlm.nih.gov/pubmed/31296202 http://dx.doi.org/10.1186/s12915-019-0672-2 |
| _version_ | 1783434144069451776 |
|---|---|
| author | Fendt, Sarah-Maria |
| author_facet | Fendt, Sarah-Maria |
| author_sort | Fendt, Sarah-Maria |
| collection | PubMed |
| description | Most cancer patients die due to metastasis formation. Therefore, understanding, preventing, and treating metastatic cancers is an unmet need. Recent research indicates that cancer cells that undergo metastasis formation have a distinct metabolism that can be targeted. Here, I would like to discuss potential opportunities in exploiting the metabolic vulnerabilities of metastasizing cancer cells. |
| format | Online Article Text |
| id | pubmed-6621976 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-66219762019-07-22 Metabolic vulnerabilities of metastasizing cancer cells Fendt, Sarah-Maria BMC Biol Question and Answer Most cancer patients die due to metastasis formation. Therefore, understanding, preventing, and treating metastatic cancers is an unmet need. Recent research indicates that cancer cells that undergo metastasis formation have a distinct metabolism that can be targeted. Here, I would like to discuss potential opportunities in exploiting the metabolic vulnerabilities of metastasizing cancer cells. BioMed Central 2019-07-11 /pmc/articles/PMC6621976/ /pubmed/31296202 http://dx.doi.org/10.1186/s12915-019-0672-2 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Question and Answer Fendt, Sarah-Maria Metabolic vulnerabilities of metastasizing cancer cells |
| title | Metabolic vulnerabilities of metastasizing cancer cells |
| title_full | Metabolic vulnerabilities of metastasizing cancer cells |
| title_fullStr | Metabolic vulnerabilities of metastasizing cancer cells |
| title_full_unstemmed | Metabolic vulnerabilities of metastasizing cancer cells |
| title_short | Metabolic vulnerabilities of metastasizing cancer cells |
| title_sort | metabolic vulnerabilities of metastasizing cancer cells |
| topic | Question and Answer |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6621976/ https://www.ncbi.nlm.nih.gov/pubmed/31296202 http://dx.doi.org/10.1186/s12915-019-0672-2 |
| work_keys_str_mv | AT fendtsarahmaria metabolicvulnerabilitiesofmetastasizingcancercells |